muricholic acid has been researched along with Metabolic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y; Chen, T; Ge, K; Guo, Y; Hu, C; Jia, W; Jiang, M; Kuang, J; Li, M; Li, Y; Lu, A; Ma, X; Ning, Z; Rajani, C; Wang, J; Wang, S; Xie, G; You, Y; Yu, H; Zhao, A; Zheng, X; Zhou, J; Zhou, S | 1 |
| Jia, W; Rajani, C; Zheng, X | 1 |
2 other study(ies) available for muricholic acid and Metabolic Diseases
| Article | Year |
|---|---|
Hyocholic acid species as novel biomarkers for metabolic disorders.
Topics: Adult; Biomarkers; Cholic Acids; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Feces; Female; Humans; Longitudinal Studies; Male; Metabolic Diseases; Middle Aged; Obesity; Overweight; Prediabetic State; Prospective Studies | 2021 |
Hyocholic acid and glycemic regulation: comments on 'Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism'.
Topics: Animals; Bile Acids and Salts; Biomarkers; Cholic Acids; Glucose; Glycemic Control; Homeostasis; Humans; Metabolic Diseases; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Signal Transduction | 2021 |